BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 790876 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)C1CC1 InChI=1S/C20H22N6O2/c1-13-6-7-15(18-23-19(28-24-18)14-8-9-14)12-25(13)20(27)16-4-2-3-5-17(16)26-21-10-11-22-26/h2-5,10-11,13-15H,6-9,12H2,1H3/t13-,15-/m1/s1 PYWWMAARZLUNBV-UKRRQHHQSA-N 395662 (2R,5R)-5-(5-Cyclopropyl-1,2,4-oxadiazol-3-yl)-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine::US10308645, Example 1 Orexin receptor type 2 Homo sapiens 329 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395662&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121344992 405265741 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790877 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)C1CC1 InChI=1S/C20H22N6O2/c1-13-6-7-15(18-23-19(28-24-18)14-8-9-14)12-25(13)20(27)16-4-2-3-5-17(16)26-21-10-11-22-26/h2-5,10-11,13-15H,6-9,12H2,1H3/t13-,15-/m1/s1 PYWWMAARZLUNBV-UKRRQHHQSA-N 395662 (2R,5R)-5-(5-Cyclopropyl-1,2,4-oxadiazol-3-yl)-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine::US10308645, Example 1 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395662&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121344992 405265741 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790878 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)C(C)(C)C InChI=1S/C21H26N6O2/c1-14-9-10-15(18-24-20(29-25-18)21(2,3)4)13-26(14)19(28)16-7-5-6-8-17(16)27-22-11-12-23-27/h5-8,11-12,14-15H,9-10,13H2,1-4H3/t14-,15-/m1/s1 AULRXDWHMQJELD-HUUCEWRRSA-N 395663 (2R,5R)-5-(5-tert-butyl-1,2,4- oxadiazol-3-yl)-2-methyl-1-{[2-(2H- 1,2,3-triazol-2- yl)phenyl]carbonyl}piperidine::US10308645, Example 2 Orexin receptor type 2 Homo sapiens 29.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395663&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314644 405265742 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790879 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)C(C)(C)C InChI=1S/C21H26N6O2/c1-14-9-10-15(18-24-20(29-25-18)21(2,3)4)13-26(14)19(28)16-7-5-6-8-17(16)27-22-11-12-23-27/h5-8,11-12,14-15H,9-10,13H2,1-4H3/t14-,15-/m1/s1 AULRXDWHMQJELD-HUUCEWRRSA-N 395663 (2R,5R)-5-(5-tert-butyl-1,2,4- oxadiazol-3-yl)-2-methyl-1-{[2-(2H- 1,2,3-triazol-2- yl)phenyl]carbonyl}piperidine::US10308645, Example 2 Orexin/Hypocretin receptor type 1 Homo sapiens 516 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395663&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314644 405265742 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790880 CCc1nc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C19H22N6O2/c1-3-17-22-18(23-27-17)14-9-8-13(2)24(12-14)19(26)15-6-4-5-7-16(15)25-20-10-11-21-25/h4-7,10-11,13-14H,3,8-9,12H2,1-2H3/t13-,14-/m1/s1 GPMBANFZQQENLZ-ZIAGYGMSSA-N 395664 (2R,5R)-5-(5-ethyl-1,2,4-oxadiazol- 3-yl)-2-methyl-1-{[2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidine::US10308645, Example 3 Orexin receptor type 2 Homo sapiens 315 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395664&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314645 405265743 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790881 CCc1nc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C19H22N6O2/c1-3-17-22-18(23-27-17)14-9-8-13(2)24(12-14)19(26)15-6-4-5-7-16(15)25-20-10-11-21-25/h4-7,10-11,13-14H,3,8-9,12H2,1-2H3/t13-,14-/m1/s1 GPMBANFZQQENLZ-ZIAGYGMSSA-N 395664 (2R,5R)-5-(5-ethyl-1,2,4-oxadiazol- 3-yl)-2-methyl-1-{[2-(2H-1,2,3- triazol-2- yl)phenyl]carbonyl}piperidine::US10308645, Example 3 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395664&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314645 405265743 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790882 CC(C)c1nc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H24N6O2/c1-13(2)19-23-18(24-28-19)15-9-8-14(3)25(12-15)20(27)16-6-4-5-7-17(16)26-21-10-11-22-26/h4-7,10-11,13-15H,8-9,12H2,1-3H3/t14-,15-/m1/s1 TZDYIXGRAKBVPX-HUUCEWRRSA-N 395665 (2R,5R)-2-methyl-5-[5-(1- methylethyl)-1,2,4-oxadiazol-3-yl]- 1-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidine::US10308645, Example 4 Orexin receptor type 2 Homo sapiens 28.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395665&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314646 405265744 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790883 CC(C)c1nc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H24N6O2/c1-13(2)19-23-18(24-28-19)15-9-8-14(3)25(12-15)20(27)16-6-4-5-7-17(16)26-21-10-11-22-26/h4-7,10-11,13-15H,8-9,12H2,1-3H3/t14-,15-/m1/s1 TZDYIXGRAKBVPX-HUUCEWRRSA-N 395665 (2R,5R)-2-methyl-5-[5-(1- methylethyl)-1,2,4-oxadiazol-3-yl]- 1-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidine::US10308645, Example 4 Orexin/Hypocretin receptor type 1 Homo sapiens 699 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395665&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314646 405265744 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790884 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)C(C)(C)O InChI=1S/C20H24N6O3/c1-13-8-9-14(17-23-19(29-24-17)20(2,3)28)12-25(13)18(27)15-6-4-5-7-16(15)26-21-10-11-22-26/h4-7,10-11,13-14,28H,8-9,12H2,1-3H3/t13-,14-/m1/s1 PTUXZXMCZHDPBE-ZIAGYGMSSA-N 395666 2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol-5-yl}propan-2-ol::US10308645, Example 5 Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395666&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305975 405265745 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790885 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)C(C)(C)O InChI=1S/C20H24N6O3/c1-13-8-9-14(17-23-19(29-24-17)20(2,3)28)12-25(13)18(27)15-6-4-5-7-16(15)26-21-10-11-22-26/h4-7,10-11,13-14,28H,8-9,12H2,1-3H3/t13-,14-/m1/s1 PTUXZXMCZHDPBE-ZIAGYGMSSA-N 395666 2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol-5-yl}propan-2-ol::US10308645, Example 5 Orexin/Hypocretin receptor type 1 Homo sapiens 3177 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395666&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305975 405265745 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790886 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)[C@](C)(O)C(F)(F)F InChI=1S/C20H21F3N6O3/c1-12-7-8-13(16-26-18(32-27-16)19(2,31)20(21,22)23)11-28(12)17(30)14-5-3-4-6-15(14)29-24-9-10-25-29/h3-6,9-10,12-13,31H,7-8,11H2,1-2H3/t12-,13-,19+/m1/s1 KPGZOEVIQMVXEA-VPZZIHKRSA-N 395667 (2S)-1,1,1-trifluoro-2-{3-[(3R,6R)- 6-methyl-1-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3-yl]- 1,2,4-oxadiazol-5-yl}propan-2-ol::US10308645, Example 6 Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395667&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314677 405265746 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790887 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)[C@](C)(O)C(F)(F)F InChI=1S/C20H21F3N6O3/c1-12-7-8-13(16-26-18(32-27-16)19(2,31)20(21,22)23)11-28(12)17(30)14-5-3-4-6-15(14)29-24-9-10-25-29/h3-6,9-10,12-13,31H,7-8,11H2,1-2H3/t12-,13-,19+/m1/s1 KPGZOEVIQMVXEA-VPZZIHKRSA-N 395667 (2S)-1,1,1-trifluoro-2-{3-[(3R,6R)- 6-methyl-1-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3-yl]- 1,2,4-oxadiazol-5-yl}propan-2-ol::US10308645, Example 6 Orexin/Hypocretin receptor type 1 Homo sapiens 288 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395667&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314677 405265746 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790888 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)[C@H](O)C(F)(F)F InChI=1S/C19H19F3N6O3/c1-11-6-7-12(16-25-17(31-26-16)15(29)19(20,21)22)10-27(11)18(30)13-4-2-3-5-14(13)28-23-8-9-24-28/h2-5,8-9,11-12,15,29H,6-7,10H2,1H3/t11-,12-,15+/m1/s1 RTKYKZDHMOEJRY-JMSVASOKSA-N 395668 (1S)-2,2,2-trifluoro-1-{3-[(3R,6R)- 6-methyl-1-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3-yl]- 1,2,4-oxadiazol-5-yl}ethanol::US10308645, Example 7 Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395668&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314676 405265747 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790889 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)[C@H](O)C(F)(F)F InChI=1S/C19H19F3N6O3/c1-11-6-7-12(16-25-17(31-26-16)15(29)19(20,21)22)10-27(11)18(30)13-4-2-3-5-14(13)28-23-8-9-24-28/h2-5,8-9,11-12,15,29H,6-7,10H2,1H3/t11-,12-,15+/m1/s1 RTKYKZDHMOEJRY-JMSVASOKSA-N 395668 (1S)-2,2,2-trifluoro-1-{3-[(3R,6R)- 6-methyl-1-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3-yl]- 1,2,4-oxadiazol-5-yl}ethanol::US10308645, Example 7 Orexin/Hypocretin receptor type 1 Homo sapiens 456 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395668&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314676 405265747 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790890 COC(C)(C)c1nc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H26N6O3/c1-14-9-10-15(18-24-20(30-25-18)21(2,3)29-4)13-26(14)19(28)16-7-5-6-8-17(16)27-22-11-12-23-27/h5-8,11-12,14-15H,9-10,13H2,1-4H3/t14-,15-/m1/s1 FVZFYDRHSOIRFS-HUUCEWRRSA-N 395669 (2R,5R)-5-[5-(1-Methoxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine::US10308645, Example 8 Orexin receptor type 2 Homo sapiens 98.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395669&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305968 405265748 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790891 COC(C)(C)c1nc(no1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H26N6O3/c1-14-9-10-15(18-24-20(30-25-18)21(2,3)29-4)13-26(14)19(28)16-7-5-6-8-17(16)27-22-11-12-23-27/h5-8,11-12,14-15H,9-10,13H2,1-4H3/t14-,15-/m1/s1 FVZFYDRHSOIRFS-HUUCEWRRSA-N 395669 (2R,5R)-5-[5-(1-Methoxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine::US10308645, Example 8 Orexin/Hypocretin receptor type 1 Homo sapiens 3698 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395669&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305968 405265748 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790892 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)[C@@H](O)C(F)(F)F InChI=1S/C19H19F3N6O3/c1-11-6-7-12(16-25-17(31-26-16)15(29)19(20,21)22)10-27(11)18(30)13-4-2-3-5-14(13)28-23-8-9-24-28/h2-5,8-9,11-12,15,29H,6-7,10H2,1H3/t11-,12-,15-/m1/s1 RTKYKZDHMOEJRY-LALPHHSUSA-N 395670 (1R)-2,2,2-Trifluoro-1-{3-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol-5-yl}ethanol::US10308645, Example 9 Orexin receptor type 2 Homo sapiens 77.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395670&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132057932 405265749 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790893 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)[C@@H](O)C(F)(F)F InChI=1S/C19H19F3N6O3/c1-11-6-7-12(16-25-17(31-26-16)15(29)19(20,21)22)10-27(11)18(30)13-4-2-3-5-14(13)28-23-8-9-24-28/h2-5,8-9,11-12,15,29H,6-7,10H2,1H3/t11-,12-,15-/m1/s1 RTKYKZDHMOEJRY-LALPHHSUSA-N 395670 (1R)-2,2,2-Trifluoro-1-{3-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol-5-yl}ethanol::US10308645, Example 9 Orexin/Hypocretin receptor type 1 Homo sapiens 1006 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395670&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132057932 405265749 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790894 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)[C@@](C)(O)C(F)(F)F InChI=1S/C20H21F3N6O3/c1-12-7-8-13(16-26-18(32-27-16)19(2,31)20(21,22)23)11-28(12)17(30)14-5-3-4-6-15(14)29-24-9-10-25-29/h3-6,9-10,12-13,31H,7-8,11H2,1-2H3/t12-,13-,19-/m1/s1 KPGZOEVIQMVXEA-VLXJIEOASA-N 395671 (2R)-1,1,1-Trifluoro-2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol-5-yl}propan-2-ol::US10308645, Example 10 Orexin receptor type 2 Homo sapiens 97.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395671&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 132057933 405265750 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790895 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1noc(n1)[C@@](C)(O)C(F)(F)F InChI=1S/C20H21F3N6O3/c1-12-7-8-13(16-26-18(32-27-16)19(2,31)20(21,22)23)11-28(12)17(30)14-5-3-4-6-15(14)29-24-9-10-25-29/h3-6,9-10,12-13,31H,7-8,11H2,1-2H3/t12-,13-,19-/m1/s1 KPGZOEVIQMVXEA-VLXJIEOASA-N 395671 (2R)-1,1,1-Trifluoro-2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol-5-yl}propan-2-ol::US10308645, Example 10 Orexin/Hypocretin receptor type 1 Homo sapiens 2241 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395671&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 132057933 405265750 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790896 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1noc(n1)C(C)(C)O InChI=1S/C22H26N4O3/c1-14-8-9-15(18-24-20(29-25-18)21(2,3)28)12-26(14)19(27)16-6-4-5-7-17(16)22(13-23)10-11-22/h4-7,14-15,28H,8-12H2,1-3H3/t14-,15-/m1/s1 ICBVGAKDTRMSFI-HUUCEWRRSA-N 395672 1-[2-({(2R,5R)-5-[5-(1-hydroxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]-2-methylpiperidin-1-yl}carbonyl)phenyl]cyclopropanecarbonitrile::US10308645, Example 11 Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395672&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305966 405265751 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790897 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1noc(n1)C(C)(C)O InChI=1S/C22H26N4O3/c1-14-8-9-15(18-24-20(29-25-18)21(2,3)28)12-26(14)19(27)16-6-4-5-7-17(16)22(13-23)10-11-22/h4-7,14-15,28H,8-12H2,1-3H3/t14-,15-/m1/s1 ICBVGAKDTRMSFI-HUUCEWRRSA-N 395672 1-[2-({(2R,5R)-5-[5-(1-hydroxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]-2-methylpiperidin-1-yl}carbonyl)phenyl]cyclopropanecarbonitrile::US10308645, Example 11 Orexin/Hypocretin receptor type 1 Homo sapiens 2291 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395672&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305966 405265751 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790898 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1noc(n1)C(C)(C)O InChI=1S/C19H23N7O3/c1-12-8-9-13(16-22-18(29-23-16)19(2,3)28)10-25(12)17(27)14-6-4-5-7-15(14)26-21-11-20-24-26/h4-7,11-13,28H,8-10H2,1-3H3/t12-,13-/m1/s1 FNYZXCNSTQAKRI-CHWSQXEVSA-N 395673 2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-tetrazol-2- yl)phenyl]carbonyl}piperidin-3-yl]-1,2,4- oxadiazol-5-yl}propan-2-ol::US10308645, Example 12 Orexin receptor type 2 Homo sapiens 184 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395673&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314603 405265752 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790899 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1noc(n1)C(C)(C)O InChI=1S/C19H23N7O3/c1-12-8-9-13(16-22-18(29-23-16)19(2,3)28)10-25(12)17(27)14-6-4-5-7-15(14)26-21-11-20-24-26/h4-7,11-13,28H,8-10H2,1-3H3/t12-,13-/m1/s1 FNYZXCNSTQAKRI-CHWSQXEVSA-N 395673 2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-tetrazol-2- yl)phenyl]carbonyl}piperidin-3-yl]-1,2,4- oxadiazol-5-yl}propan-2-ol::US10308645, Example 12 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395673&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314603 405265752 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790900 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)c1noc(n1)C(C)(C)O InChI=1S/C18H22N6O3S/c1-11-4-5-12(14-21-17(27-22-14)18(2,3)26)10-23(11)15(25)13-6-9-28-16(13)24-19-7-8-20-24/h6-9,11-12,26H,4-5,10H2,1-3H3/t11-,12-/m1/s1 QVKTUUIDPKSFBE-VXGBXAGGSA-N 395674 2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3- triazol-2-yl)thiophen-3- yl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol- 5-yl}propan-2-ol::US10308645, Example 13 Orexin receptor type 2 Homo sapiens 39.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395674&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314604 405265753 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790901 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)c1noc(n1)C(C)(C)O InChI=1S/C18H22N6O3S/c1-11-4-5-12(14-21-17(27-22-14)18(2,3)26)10-23(11)15(25)13-6-9-28-16(13)24-19-7-8-20-24/h6-9,11-12,26H,4-5,10H2,1-3H3/t11-,12-/m1/s1 QVKTUUIDPKSFBE-VXGBXAGGSA-N 395674 2-{3-[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3- triazol-2-yl)thiophen-3- yl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol- 5-yl}propan-2-ol::US10308645, Example 13 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395674&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314604 405265753 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790902 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)c1noc(n1)C(C)(C)O InChI=1S/C18H22N6O3S/c1-11-4-5-12(15-21-17(27-22-15)18(2,3)26)8-23(11)16(25)13-9-28-10-14(13)24-19-6-7-20-24/h6-7,9-12,26H,4-5,8H2,1-3H3/t11-,12-/m1/s1 UPBLEIDUMYAKLU-VXGBXAGGSA-N 395675 2-{3-[(3R,6R)-6-methyl-1-{[4-(2H-1,2,3- triazol-2-yl)thiophen-3- yl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol- 5-yl}propan-2-ol::US10308645, Example 14 Orexin receptor type 2 Homo sapiens 48.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395675&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314714 405265754 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790903 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)c1noc(n1)C(C)(C)O InChI=1S/C18H22N6O3S/c1-11-4-5-12(15-21-17(27-22-15)18(2,3)26)8-23(11)16(25)13-9-28-10-14(13)24-19-6-7-20-24/h6-7,9-12,26H,4-5,8H2,1-3H3/t11-,12-/m1/s1 UPBLEIDUMYAKLU-VXGBXAGGSA-N 395675 2-{3-[(3R,6R)-6-methyl-1-{[4-(2H-1,2,3- triazol-2-yl)thiophen-3- yl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol- 5-yl}propan-2-ol::US10308645, Example 14 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395675&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314714 405265754 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790904 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OC(F)(F)F)c1noc(n1)C(C)(C)O InChI=1S/C19H22F3N3O4/c1-11-8-9-12(15-23-17(29-24-15)18(2,3)27)10-25(11)16(26)13-6-4-5-7-14(13)28-19(20,21)22/h4-7,11-12,27H,8-10H2,1-3H3/t11-,12-/m1/s1 NLYNKNHYNZVZME-VXGBXAGGSA-N 395676 2-{3-[(3R,6R)-6-methyl-1-{[2- (trifluoromethoxy)phenyl]carbonyl}piperidin- 3-yl]-1,2,4-oxadiazol-5-yl}propan-2-ol::US10308645, Example 15 Orexin receptor type 2 Homo sapiens 86.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395676&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314713 405265755 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790905 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OC(F)(F)F)c1noc(n1)C(C)(C)O InChI=1S/C19H22F3N3O4/c1-11-8-9-12(15-23-17(29-24-15)18(2,3)27)10-25(11)16(26)13-6-4-5-7-14(13)28-19(20,21)22/h4-7,11-12,27H,8-10H2,1-3H3/t11-,12-/m1/s1 NLYNKNHYNZVZME-VXGBXAGGSA-N 395676 2-{3-[(3R,6R)-6-methyl-1-{[2- (trifluoromethoxy)phenyl]carbonyl}piperidin- 3-yl]-1,2,4-oxadiazol-5-yl}propan-2-ol::US10308645, Example 15 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395676&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314713 405265755 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790906 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)(F)F)c1noc(n1)C(C)(C)O InChI=1S/C19H23F3N4O4/c1-11-6-7-12(14-24-17(30-25-14)18(2,3)28)9-26(11)16(27)13-5-4-8-23-15(13)29-10-19(20,21)22/h4-5,8,11-12,28H,6-7,9-10H2,1-3H3/t11-,12-/m1/s1 KTNDVWLRJJQSIT-VXGBXAGGSA-N 395677 2-{3-[(3R,6R)-6-methyl-1-{[2-(2,2,2- trifluoroethoxy)pyridin-3- yl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol- 5-yl}propan-2-ol::US10308645, Example 16 Orexin receptor type 2 Homo sapiens 87.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395677&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314709 405265756 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790907 C[C@@H]1CC[C@H](CN1C(=O)c1cccnc1OCC(F)(F)F)c1noc(n1)C(C)(C)O InChI=1S/C19H23F3N4O4/c1-11-6-7-12(14-24-17(30-25-14)18(2,3)28)9-26(11)16(27)13-5-4-8-23-15(13)29-10-19(20,21)22/h4-5,8,11-12,28H,6-7,9-10H2,1-3H3/t11-,12-/m1/s1 KTNDVWLRJJQSIT-VXGBXAGGSA-N 395677 2-{3-[(3R,6R)-6-methyl-1-{[2-(2,2,2- trifluoroethoxy)pyridin-3- yl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol- 5-yl}propan-2-ol::US10308645, Example 16 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395677&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314709 405265756 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790908 CC(C)Oc1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)c1noc(n1)C(C)(C)O InChI=1S/C20H28N4O4/c1-12(2)27-17-15(7-6-10-21-17)18(25)24-11-14(9-8-13(24)3)16-22-19(28-23-16)20(4,5)26/h6-7,10,12-14,26H,8-9,11H2,1-5H3/t13-,14-/m1/s1 OGESQOXBYICAHA-ZIAGYGMSSA-N 395678 2-{3-[(3R,6R)-6-methyl-1-{[2-(1- methylethoxy)pyridin-3- yl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol- 5-yl}propan-2-ol::US10308645, Example 17 Orexin receptor type 2 Homo sapiens 219 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395678&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314716 405265757 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790909 CC(C)Oc1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)c1noc(n1)C(C)(C)O InChI=1S/C20H28N4O4/c1-12(2)27-17-15(7-6-10-21-17)18(25)24-11-14(9-8-13(24)3)16-22-19(28-23-16)20(4,5)26/h6-7,10,12-14,26H,8-9,11H2,1-5H3/t13-,14-/m1/s1 OGESQOXBYICAHA-ZIAGYGMSSA-N 395678 2-{3-[(3R,6R)-6-methyl-1-{[2-(1- methylethoxy)pyridin-3- yl]carbonyl}piperidin-3-yl]-1,2,4-oxadiazol- 5-yl}propan-2-ol::US10308645, Example 17 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395678&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314716 405265757 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790910 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OC(F)F)c1noc(n1)C(C)(C)O InChI=1S/C19H23F2N3O4/c1-11-8-9-12(15-22-17(28-23-15)19(2,3)26)10-24(11)16(25)13-6-4-5-7-14(13)27-18(20)21/h4-7,11-12,18,26H,8-10H2,1-3H3/t11-,12-/m1/s1 BASBUQZJGVZEAO-VXGBXAGGSA-N 395679 2-{3-[(3R,6R)-1-{[2- (difluoromethoxy)phenyl]carbonyl}-6- methylpiperidin-3-yl]-1,2,4-oxadiazol-5- yl}propan-2-ol::US10308645, Example 18 Orexin receptor type 2 Homo sapiens 140 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395679&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314711 405265758 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790911 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OC(F)F)c1noc(n1)C(C)(C)O InChI=1S/C19H23F2N3O4/c1-11-8-9-12(15-22-17(28-23-15)19(2,3)26)10-24(11)16(25)13-6-4-5-7-14(13)27-18(20)21/h4-7,11-12,18,26H,8-10H2,1-3H3/t11-,12-/m1/s1 BASBUQZJGVZEAO-VXGBXAGGSA-N 395679 2-{3-[(3R,6R)-1-{[2- (difluoromethoxy)phenyl]carbonyl}-6- methylpiperidin-3-yl]-1,2,4-oxadiazol-5- yl}propan-2-ol::US10308645, Example 18 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395679&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314711 405265758 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790912 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1noc(n1)C(C)(C)O InChI=1S/C20H27N3O4/c1-5-26-16-9-7-6-8-15(16)18(24)23-12-14(11-10-13(23)2)17-21-19(27-22-17)20(3,4)25/h6-9,13-14,25H,5,10-12H2,1-4H3/t13-,14-/m1/s1 SQTJLGCSXYDUFJ-ZIAGYGMSSA-N 395680 2-(3-{(3R,6R)-1-[(2-ethoxyphenyl)carbonyl]- 6-methylpiperidin-3-yl}-1,2,4-oxadiazol-5- yl)propan-2-ol::US10308645, Example 19 Orexin receptor type 2 Homo sapiens 124 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395680&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305970 405265759 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790913 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1noc(n1)C(C)(C)O InChI=1S/C20H27N3O4/c1-5-26-16-9-7-6-8-15(16)18(24)23-12-14(11-10-13(23)2)17-21-19(27-22-17)20(3,4)25/h6-9,13-14,25H,5,10-12H2,1-4H3/t13-,14-/m1/s1 SQTJLGCSXYDUFJ-ZIAGYGMSSA-N 395680 2-(3-{(3R,6R)-1-[(2-ethoxyphenyl)carbonyl]- 6-methylpiperidin-3-yl}-1,2,4-oxadiazol-5- yl)propan-2-ol::US10308645, Example 19 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395680&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305970 405265759 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790914 COC(=O)c1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1noc(n1)C(C)(C)O InChI=1S/C20H25N3O5/c1-12-9-10-13(16-21-19(28-22-16)20(2,3)26)11-23(12)17(24)14-7-5-6-8-15(14)18(25)27-4/h5-8,12-13,26H,9-11H2,1-4H3/t12-,13-/m1/s1 AGPOBLCNTFOEAF-CHWSQXEVSA-N 395681 US10308645, Example 20::methyl 2-({(2R,5R)-5-[5-(1-hydroxy-1- methylethyl)-1,2,4-oxadiazol-3-yl]-2- methylpiperidin-1-yl}carbonyl)benzoate Orexin receptor type 2 Homo sapiens 97.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395681&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305973 405265760 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790915 COC(=O)c1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1noc(n1)C(C)(C)O InChI=1S/C20H25N3O5/c1-12-9-10-13(16-21-19(28-22-16)20(2,3)26)11-23(12)17(24)14-7-5-6-8-15(14)18(25)27-4/h5-8,12-13,26H,9-11H2,1-4H3/t12-,13-/m1/s1 AGPOBLCNTFOEAF-CHWSQXEVSA-N 395681 US10308645, Example 20::methyl 2-({(2R,5R)-5-[5-(1-hydroxy-1- methylethyl)-1,2,4-oxadiazol-3-yl]-2- methylpiperidin-1-yl}carbonyl)benzoate Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395681&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305973 405265760 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790916 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)c1noc(n1)C(C)(C)O InChI=1S/C20H23FN6O3/c1-12-4-5-13(17-24-19(30-25-17)20(2,3)29)11-26(12)18(28)15-7-6-14(21)10-16(15)27-22-8-9-23-27/h6-10,12-13,29H,4-5,11H2,1-3H3/t12-,13-/m1/s1 DYYAETXCQAHRDA-CHWSQXEVSA-N 395682 2-{3-[(3R,6R)-1-{[4-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-6-methylpiperidin-3-yl]-1,2,4-oxadiazol-5-yl}propan-2-ol::US10308645, Example 21 Orexin receptor type 2 Homo sapiens 44.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395682&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314533 405265761 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790917 C[C@@H]1CC[C@H](CN1C(=O)c1ccc(F)cc1-n1nccn1)c1noc(n1)C(C)(C)O InChI=1S/C20H23FN6O3/c1-12-4-5-13(17-24-19(30-25-17)20(2,3)29)11-26(12)18(28)15-7-6-14(21)10-16(15)27-22-8-9-23-27/h6-10,12-13,29H,4-5,11H2,1-3H3/t12-,13-/m1/s1 DYYAETXCQAHRDA-CHWSQXEVSA-N 395682 2-{3-[(3R,6R)-1-{[4-Fluoro-2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}-6-methylpiperidin-3-yl]-1,2,4-oxadiazol-5-yl}propan-2-ol::US10308645, Example 21 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395682&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314533 405265761 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790918 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)c1noc(n1)C(C)(C)O InChI=1S/C20H23N5O3S/c1-12-5-6-13(16-23-19(28-24-16)20(2,3)27)11-25(12)18(26)14-7-10-29-15(14)17-21-8-4-9-22-17/h4,7-10,12-13,27H,5-6,11H2,1-3H3/t12-,13-/m1/s1 WURMKHDYJDVCJK-CHWSQXEVSA-N 395683 2-(3-{(3R,6R)-6-methyl-1-[(2- pyrimidin-2-ylthiophen-3- yl)carbonyl]piperidin-3-yl}- 1,2,4-oxadiazol-5-yl)propan-2-ol::US10308645, Example 22 Orexin receptor type 2 Homo sapiens 61.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395683&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305964 405265762 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790919 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)c1noc(n1)C(C)(C)O InChI=1S/C20H23N5O3S/c1-12-5-6-13(16-23-19(28-24-16)20(2,3)27)11-25(12)18(26)14-7-10-29-15(14)17-21-8-4-9-22-17/h4,7-10,12-13,27H,5-6,11H2,1-3H3/t12-,13-/m1/s1 WURMKHDYJDVCJK-CHWSQXEVSA-N 395683 2-(3-{(3R,6R)-6-methyl-1-[(2- pyrimidin-2-ylthiophen-3- yl)carbonyl]piperidin-3-yl}- 1,2,4-oxadiazol-5-yl)propan-2-ol::US10308645, Example 22 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395683&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305964 405265762 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790920 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1noc(n1)C(C)(C)O InChI=1S/C22H25N5O3/c1-14-9-10-15(18-25-21(30-26-18)22(2,3)29)13-27(14)20(28)17-8-5-4-7-16(17)19-23-11-6-12-24-19/h4-8,11-12,14-15,29H,9-10,13H2,1-3H3/t14-,15-/m1/s1 FXLUJEAGIYTLSP-HUUCEWRRSA-N 395684 2-(3-{(3R,6R)-6-Methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl}-1,2,4-oxadiazol-5-yl)propan-2-ol::US10308645, Example 23 Orexin receptor type 2 Homo sapiens 63.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395684&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305961 405265763 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790921 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1noc(n1)C(C)(C)O InChI=1S/C22H25N5O3/c1-14-9-10-15(18-25-21(30-26-18)22(2,3)29)13-27(14)20(28)17-8-5-4-7-16(17)19-23-11-6-12-24-19/h4-8,11-12,14-15,29H,9-10,13H2,1-3H3/t14-,15-/m1/s1 FXLUJEAGIYTLSP-HUUCEWRRSA-N 395684 2-(3-{(3R,6R)-6-Methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl}-1,2,4-oxadiazol-5-yl)propan-2-ol::US10308645, Example 23 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395684&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305961 405265763 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790922 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-c1ncccn1)c1noc(n1)C(C)(C)O InChI=1S/C20H23N5O3S/c1-12-5-6-13(16-23-19(28-24-16)20(2,3)27)9-25(12)18(26)15-11-29-10-14(15)17-21-7-4-8-22-17/h4,7-8,10-13,27H,5-6,9H2,1-3H3/t12-,13-/m1/s1 BYDIMRDQQPBULG-CHWSQXEVSA-N 395685 2-(3-{(3R,6R)-6-methyl-1-[(4- pyrimidin-2-ylthiophen-3- yl)carbonyl]piperidin-3-yl}- 1,2,4-oxadiazol-5-yl)propan-2-ol::US10308645, Example 24 Orexin receptor type 2 Homo sapiens 76.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395685&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305967 405265764 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790923 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-c1ncccn1)c1noc(n1)C(C)(C)O InChI=1S/C20H23N5O3S/c1-12-5-6-13(16-23-19(28-24-16)20(2,3)27)9-25(12)18(26)15-11-29-10-14(15)17-21-7-4-8-22-17/h4,7-8,10-13,27H,5-6,9H2,1-3H3/t12-,13-/m1/s1 BYDIMRDQQPBULG-CHWSQXEVSA-N 395685 2-(3-{(3R,6R)-6-methyl-1-[(4- pyrimidin-2-ylthiophen-3- yl)carbonyl]piperidin-3-yl}- 1,2,4-oxadiazol-5-yl)propan-2-ol::US10308645, Example 24 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395685&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305967 405265764 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790924 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1nc(no1)C(C)(C)C InChI=1S/C21H26N6O2/c1-14-9-10-15(18-24-20(25-29-18)21(2,3)4)13-26(14)19(28)16-7-5-6-8-17(16)27-22-11-12-23-27/h5-8,11-12,14-15H,9-10,13H2,1-4H3/t14-,15-/m1/s1 NAHJCTLJHLFTPA-HUUCEWRRSA-N 395686 (2R,5R)-5-(3-tert-Butyl-1,2,4-oxadiazol-5-yl)-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine::US10308645, Example 25 Orexin receptor type 2 Homo sapiens 87.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395686&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314706 405265765 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790925 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1nc(no1)C(C)(C)C InChI=1S/C21H26N6O2/c1-14-9-10-15(18-24-20(25-29-18)21(2,3)4)13-26(14)19(28)16-7-5-6-8-17(16)27-22-11-12-23-27/h5-8,11-12,14-15H,9-10,13H2,1-4H3/t14-,15-/m1/s1 NAHJCTLJHLFTPA-HUUCEWRRSA-N 395686 (2R,5R)-5-(3-tert-Butyl-1,2,4-oxadiazol-5-yl)-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine::US10308645, Example 25 Orexin/Hypocretin receptor type 1 Homo sapiens 1148 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395686&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314706 405265765 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790926 CC(C)c1noc(n1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H24N6O2/c1-13(2)18-23-19(28-24-18)15-9-8-14(3)25(12-15)20(27)16-6-4-5-7-17(16)26-21-10-11-22-26/h4-7,10-11,13-15H,8-9,12H2,1-3H3/t14-,15-/m1/s1 SVCUTBAMBVMRAP-HUUCEWRRSA-N 395687 (2R,5R)-2-methyl-5-[3-(1- methylethyl)-1,2,4-oxadiazol-5-yl]- 1-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidine::US10308645, Example 26 Orexin receptor type 2 Homo sapiens 124 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395687&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314636 405265766 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790927 CC(C)c1noc(n1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C20H24N6O2/c1-13(2)18-23-19(28-24-18)15-9-8-14(3)25(12-15)20(27)16-6-4-5-7-17(16)26-21-10-11-22-26/h4-7,10-11,13-15H,8-9,12H2,1-3H3/t14-,15-/m1/s1 SVCUTBAMBVMRAP-HUUCEWRRSA-N 395687 (2R,5R)-2-methyl-5-[3-(1- methylethyl)-1,2,4-oxadiazol-5-yl]- 1-{[2-(2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidine::US10308645, Example 26 Orexin/Hypocretin receptor type 1 Homo sapiens 4501 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395687&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314636 405265766 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790928 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1nc(no1)C(C)(C)O InChI=1S/C20H24N6O3/c1-13-8-9-14(17-23-19(24-29-17)20(2,3)28)12-25(13)18(27)15-6-4-5-7-16(15)26-21-10-11-22-26/h4-7,10-11,13-14,28H,8-9,12H2,1-3H3/t13-,14-/m1/s1 ZZIOWVMIBRYTLX-ZIAGYGMSSA-N 395688 2-{5-[(3R,6R)-6-methyl-1-{[2-(2H- 1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]-1,2,4-oxadiazol-3-yl}propan-2- ol::US10308645, Example 27 Orexin receptor type 2 Homo sapiens 75.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395688&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314637 405265767 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790929 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1nc(no1)C(C)(C)O InChI=1S/C20H24N6O3/c1-13-8-9-14(17-23-19(24-29-17)20(2,3)28)12-25(13)18(27)15-6-4-5-7-16(15)26-21-10-11-22-26/h4-7,10-11,13-14,28H,8-9,12H2,1-3H3/t13-,14-/m1/s1 ZZIOWVMIBRYTLX-ZIAGYGMSSA-N 395688 2-{5-[(3R,6R)-6-methyl-1-{[2-(2H- 1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3- yl]-1,2,4-oxadiazol-3-yl}propan-2- ol::US10308645, Example 27 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395688&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314637 405265767 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790930 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1nc(no1)C1CC1 InChI=1S/C20H22N6O2/c1-13-6-7-15(19-23-18(24-28-19)14-8-9-14)12-25(13)20(27)16-4-2-3-5-17(16)26-21-10-11-22-26/h2-5,10-11,13-15H,6-9,12H2,1H3/t13-,15-/m1/s1 XBTKDHZZNOUBMP-UKRRQHHQSA-N 395689 (2R,5R)-5-(3-cyclopropyl-1,2,4- oxadiazol-5-yl)-2-methyl-1-{[2- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidine::US10308645, Example 28 Orexin receptor type 2 Homo sapiens 345 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395689&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314638 405265768 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790931 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1nc(no1)C1CC1 InChI=1S/C20H22N6O2/c1-13-6-7-15(19-23-18(24-28-19)14-8-9-14)12-25(13)20(27)16-4-2-3-5-17(16)26-21-10-11-22-26/h2-5,10-11,13-15H,6-9,12H2,1H3/t13-,15-/m1/s1 XBTKDHZZNOUBMP-UKRRQHHQSA-N 395689 (2R,5R)-5-(3-cyclopropyl-1,2,4- oxadiazol-5-yl)-2-methyl-1-{[2- (2H-1,2,3-triazol-2- yl)phenyl]carbonyl}piperidine::US10308645, Example 28 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395689&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314638 405265768 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790932 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)c1nsc(n1)C(C)(C)O InChI=1S/C18H22N6O2S2/c1-11-4-5-12(14-21-17(28-22-14)18(2,3)26)10-23(11)15(25)13-6-9-27-16(13)24-19-7-8-20-24/h6-9,11-12,26H,4-5,10H2,1-3H3/t11-,12-/m1/s1 NVSYRADIQHDSGG-VXGBXAGGSA-N 395690 2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl]carbonyl}piperidin-3-yl]-1,2,4-thiadiazol-5-yl}propan-2-ol::US10308645, Example 29 Orexin receptor type 2 Homo sapiens 88.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395690&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314655 405265769 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790933 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-n1nccn1)c1nsc(n1)C(C)(C)O InChI=1S/C18H22N6O2S2/c1-11-4-5-12(14-21-17(28-22-14)18(2,3)26)10-23(11)15(25)13-6-9-27-16(13)24-19-7-8-20-24/h6-9,11-12,26H,4-5,10H2,1-3H3/t11-,12-/m1/s1 NVSYRADIQHDSGG-VXGBXAGGSA-N 395690 2-{3-[(3R,6R)-6-Methyl-1-{[2-(2H-1,2,3-triazol-2-yl)thiophen-3-yl]carbonyl}piperidin-3-yl]-1,2,4-thiadiazol-5-yl}propan-2-ol::US10308645, Example 29 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395690&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314655 405265769 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790934 CC(C)Oc1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)c1nsc(n1)C(C)(C)O InChI=1S/C20H28N4O3S/c1-12(2)27-17-15(7-6-10-21-17)18(25)24-11-14(9-8-13(24)3)16-22-19(28-23-16)20(4,5)26/h6-7,10,12-14,26H,8-9,11H2,1-5H3/t13-,14-/m1/s1 DOUNPXXBCVVNRL-ZIAGYGMSSA-N 395691 2-{3-[(3R,6R)-6-methyl-1-{[2-(1- methylethoxy)pyridin-3- yl]carbonyl}piperidin-3-yl]-1,2,4- thiadiazol-5-yl}propan-2-ol::US10308645, Example 30 Orexin receptor type 2 Homo sapiens 298 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395691&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314715 405265770 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790935 CC(C)Oc1ncccc1C(=O)N1C[C@@H](CC[C@H]1C)c1nsc(n1)C(C)(C)O InChI=1S/C20H28N4O3S/c1-12(2)27-17-15(7-6-10-21-17)18(25)24-11-14(9-8-13(24)3)16-22-19(28-23-16)20(4,5)26/h6-7,10,12-14,26H,8-9,11H2,1-5H3/t13-,14-/m1/s1 DOUNPXXBCVVNRL-ZIAGYGMSSA-N 395691 2-{3-[(3R,6R)-6-methyl-1-{[2-(1- methylethoxy)pyridin-3- yl]carbonyl}piperidin-3-yl]-1,2,4- thiadiazol-5-yl}propan-2-ol::US10308645, Example 30 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395691&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314715 405265770 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790936 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)c1nsc(n1)C(C)(C)O InChI=1S/C18H22N6O2S2/c1-11-4-5-12(15-21-17(28-22-15)18(2,3)26)8-23(11)16(25)13-9-27-10-14(13)24-19-6-7-20-24/h6-7,9-12,26H,4-5,8H2,1-3H3/t11-,12-/m1/s1 NCYQEDRSFBNUSC-VXGBXAGGSA-N 395692 2-{3-[(3R,6R)-6-methyl-1-{[4-(2H- 1,2,3-triazol-2-yl)thiophen-3- yl]carbonyl}piperidin-3-yl]-1,2,4- thiadiazol-5-yl}propan-2-ol::US10308645, Example 31 Orexin receptor type 2 Homo sapiens 110 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395692&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314574 405265771 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790937 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-n1nccn1)c1nsc(n1)C(C)(C)O InChI=1S/C18H22N6O2S2/c1-11-4-5-12(15-21-17(28-22-15)18(2,3)26)8-23(11)16(25)13-9-27-10-14(13)24-19-6-7-20-24/h6-7,9-12,26H,4-5,8H2,1-3H3/t11-,12-/m1/s1 NCYQEDRSFBNUSC-VXGBXAGGSA-N 395692 2-{3-[(3R,6R)-6-methyl-1-{[4-(2H- 1,2,3-triazol-2-yl)thiophen-3- yl]carbonyl}piperidin-3-yl]-1,2,4- thiadiazol-5-yl}propan-2-ol::US10308645, Example 31 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395692&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314574 405265771 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790938 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1nsc(n1)C(C)(C)O InChI=1S/C22H26N4O2S/c1-14-8-9-15(18-24-20(29-25-18)21(2,3)28)12-26(14)19(27)16-6-4-5-7-17(16)22(13-23)10-11-22/h4-7,14-15,28H,8-12H2,1-3H3/t14-,15-/m1/s1 WAYULQGSWBEHIR-HUUCEWRRSA-N 395693 1-[2-({(2R,5R)-5-[5-(1-hydroxy-1- methylethyl)-1,2,4-thiadiazol-3-yl]- 2-methylpiperidin-1- yl}carbonyl)phenyl]cyclopropane- carbonitrile::US10308645, Example 32 Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395693&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305972 405265772 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790939 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1(CC1)C#N)c1nsc(n1)C(C)(C)O InChI=1S/C22H26N4O2S/c1-14-8-9-15(18-24-20(29-25-18)21(2,3)28)12-26(14)19(27)16-6-4-5-7-17(16)22(13-23)10-11-22/h4-7,14-15,28H,8-12H2,1-3H3/t14-,15-/m1/s1 WAYULQGSWBEHIR-HUUCEWRRSA-N 395693 1-[2-({(2R,5R)-5-[5-(1-hydroxy-1- methylethyl)-1,2,4-thiadiazol-3-yl]- 2-methylpiperidin-1- yl}carbonyl)phenyl]cyclopropane- carbonitrile::US10308645, Example 32 Orexin/Hypocretin receptor type 1 Homo sapiens 2416 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395693&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305972 405265772 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790940 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)c1nsc(n1)C(C)(C)O InChI=1S/C20H27N3O4S2/c1-13-9-10-14(17-21-19(28-22-17)20(2,3)25)11-23(13)18(24)16-8-6-5-7-15(16)12-29(4,26)27/h5-8,13-14,25H,9-12H2,1-4H3/t13-,14-/m1/s1 AJJUVSQDFMETJV-ZIAGYGMSSA-N 395694 2-{3-[(3R,6R)-6-methyl-1-({2- [(methylsulfonyl)methyl]phenyl} carbonyl)piperidin-3-yl]-1,2,4- thiadiazol-5-l}propan-2-ol::US10308645, Example 33 Orexin receptor type 2 Homo sapiens 194 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395694&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314579 405265773 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790941 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1CS(C)(=O)=O)c1nsc(n1)C(C)(C)O InChI=1S/C20H27N3O4S2/c1-13-9-10-14(17-21-19(28-22-17)20(2,3)25)11-23(13)18(24)16-8-6-5-7-15(16)12-29(4,26)27/h5-8,13-14,25H,9-12H2,1-4H3/t13-,14-/m1/s1 AJJUVSQDFMETJV-ZIAGYGMSSA-N 395694 2-{3-[(3R,6R)-6-methyl-1-({2- [(methylsulfonyl)methyl]phenyl} carbonyl)piperidin-3-yl]-1,2,4- thiadiazol-5-l}propan-2-ol::US10308645, Example 33 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395694&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314579 405265773 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790942 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1nsc(n1)C(C)(C)O InChI=1S/C19H23N7O2S/c1-12-8-9-13(16-22-18(29-23-16)19(2,3)28)10-25(12)17(27)14-6-4-5-7-15(14)26-21-11-20-24-26/h4-7,11-13,28H,8-10H2,1-3H3/t12-,13-/m1/s1 OTAALEBMKTYWLX-CHWSQXEVSA-N 395695 2-{3-[(3R,6R)-6-methyl-1-{[2-(2H- tetrazol-2- yl)phenyl]carbonyl}piperidin-3-yl]- 1,2,4-thiadiazol-5-yl}propan-2-ol::US10308645, Example 34 Orexin receptor type 2 Homo sapiens 339 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395695&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314576 405265774 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790943 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1nsc(n1)C(C)(C)O InChI=1S/C19H23N7O2S/c1-12-8-9-13(16-22-18(29-23-16)19(2,3)28)10-25(12)17(27)14-6-4-5-7-15(14)26-21-11-20-24-26/h4-7,11-13,28H,8-10H2,1-3H3/t12-,13-/m1/s1 OTAALEBMKTYWLX-CHWSQXEVSA-N 395695 2-{3-[(3R,6R)-6-methyl-1-{[2-(2H- tetrazol-2- yl)phenyl]carbonyl}piperidin-3-yl]- 1,2,4-thiadiazol-5-yl}propan-2-ol::US10308645, Example 34 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395695&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314576 405265774 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790944 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1nsc(n1)C(C)(C)O InChI=1S/C20H24N6O2S/c1-13-8-9-14(17-23-19(29-24-17)20(2,3)28)12-25(13)18(27)15-6-4-5-7-16(15)26-21-10-11-22-26/h4-7,10-11,13-14,28H,8-9,12H2,1-3H3/t13-,14-/m1/s1 YDZDAVMPLAEKGE-ZIAGYGMSSA-N 395696 2-{3-[(3R,6R)-6-methyl-1-{[2-(2H- 1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3-yl]- 1,2,4-thiadiazol-5-yl}propan-2-ol::US10308645, Example 35 Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395696&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314536 405265775 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790945 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)c1nsc(n1)C(C)(C)O InChI=1S/C20H24N6O2S/c1-13-8-9-14(17-23-19(29-24-17)20(2,3)28)12-25(13)18(27)15-6-4-5-7-16(15)26-21-10-11-22-26/h4-7,10-11,13-14,28H,8-9,12H2,1-3H3/t13-,14-/m1/s1 YDZDAVMPLAEKGE-ZIAGYGMSSA-N 395696 2-{3-[(3R,6R)-6-methyl-1-{[2-(2H- 1,2,3-triazol-2- yl)phenyl]carbonyl}piperidin-3-yl]- 1,2,4-thiadiazol-5-yl}propan-2-ol::US10308645, Example 35 Orexin/Hypocretin receptor type 1 Homo sapiens 2382 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395696&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314536 405265775 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790946 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OC(F)F)c1nsc(n1)C(C)(C)O InChI=1S/C19H23F2N3O3S/c1-11-8-9-12(15-22-17(28-23-15)19(2,3)26)10-24(11)16(25)13-6-4-5-7-14(13)27-18(20)21/h4-7,11-12,18,26H,8-10H2,1-3H3/t11-,12-/m1/s1 WDVWIICLSVLDGM-VXGBXAGGSA-N 395697 2-{3-[(3R,6R)-1-{[2- (difluoromethoxy)phenyl]carbonyl}- 6-methylpiperidin-3-yl]-1,2,4- thiadiazol-5-yl}propan-2-ol::US10308645, Example 36 Orexin receptor type 2 Homo sapiens 243 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395697&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314578 405265776 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790947 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OC(F)F)c1nsc(n1)C(C)(C)O InChI=1S/C19H23F2N3O3S/c1-11-8-9-12(15-22-17(28-23-15)19(2,3)26)10-24(11)16(25)13-6-4-5-7-14(13)27-18(20)21/h4-7,11-12,18,26H,8-10H2,1-3H3/t11-,12-/m1/s1 WDVWIICLSVLDGM-VXGBXAGGSA-N 395697 2-{3-[(3R,6R)-1-{[2- (difluoromethoxy)phenyl]carbonyl}- 6-methylpiperidin-3-yl]-1,2,4- thiadiazol-5-yl}propan-2-ol::US10308645, Example 36 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395697&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314578 405265776 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790948 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1nsc(n1)C(C)(C)O InChI=1S/C20H27N3O3S/c1-5-26-16-9-7-6-8-15(16)18(24)23-12-14(11-10-13(23)2)17-21-19(27-22-17)20(3,4)25/h6-9,13-14,25H,5,10-12H2,1-4H3/t13-,14-/m1/s1 KDIOSWPDFTWRRZ-ZIAGYGMSSA-N 395698 2-(3-{(3R,6R)-1-[(2- ethoxyphenyl)carbonyl]-6- methylpiperidin-3-yl}-1,2,4- thiadiazol-5-yl)propan-2-ol::US10308645, Example 37 Orexin receptor type 2 Homo sapiens 146 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395698&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305974 405265777 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790949 CCOc1ccccc1C(=O)N1C[C@@H](CC[C@H]1C)c1nsc(n1)C(C)(C)O InChI=1S/C20H27N3O3S/c1-5-26-16-9-7-6-8-15(16)18(24)23-12-14(11-10-13(23)2)17-21-19(27-22-17)20(3,4)25/h6-9,13-14,25H,5,10-12H2,1-4H3/t13-,14-/m1/s1 KDIOSWPDFTWRRZ-ZIAGYGMSSA-N 395698 2-(3-{(3R,6R)-1-[(2- ethoxyphenyl)carbonyl]-6- methylpiperidin-3-yl}-1,2,4- thiadiazol-5-yl)propan-2-ol::US10308645, Example 37 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395698&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305974 405265777 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790950 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OCC(F)(F)F)c1nsc(n1)C(C)(C)O InChI=1S/C20H24F3N3O3S/c1-12-8-9-13(16-24-18(30-25-16)19(2,3)28)10-26(12)17(27)14-6-4-5-7-15(14)29-11-20(21,22)23/h4-7,12-13,28H,8-11H2,1-3H3/t12-,13-/m1/s1 ZOCRWKCJVRVUBP-CHWSQXEVSA-N 395699 2-{3-[(3R,6R)-6-methyl-1-{[2- (2,2,2-trifluoroethoxy)pyridin-3- yl]carbonyl}piperidin-3-yl]-1,2,4- thiadiazol-5-yl}propan-2-ol::US10308645, Example 38 Orexin receptor type 2 Homo sapiens 124 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395699&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314582 405265778 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790951 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OCC(F)(F)F)c1nsc(n1)C(C)(C)O InChI=1S/C20H24F3N3O3S/c1-12-8-9-13(16-24-18(30-25-16)19(2,3)28)10-26(12)17(27)14-6-4-5-7-15(14)29-11-20(21,22)23/h4-7,12-13,28H,8-11H2,1-3H3/t12-,13-/m1/s1 ZOCRWKCJVRVUBP-CHWSQXEVSA-N 395699 2-{3-[(3R,6R)-6-methyl-1-{[2- (2,2,2-trifluoroethoxy)pyridin-3- yl]carbonyl}piperidin-3-yl]-1,2,4- thiadiazol-5-yl}propan-2-ol::US10308645, Example 38 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395699&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314582 405265778 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790952 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OC(F)(F)F)c1nsc(n1)C(C)(C)O InChI=1S/C19H22F3N3O3S/c1-11-8-9-12(15-23-17(29-24-15)18(2,3)27)10-25(11)16(26)13-6-4-5-7-14(13)28-19(20,21)22/h4-7,11-12,27H,8-10H2,1-3H3/t11-,12-/m1/s1 MBIBUCDOLLSHMQ-VXGBXAGGSA-N 395700 2-{3-[(3R,6R)-6-methyl-1-{[2- (trifluoromethoxy)phenyl]carbonyl} piperidin-3-yl]-1,2,4-thiadiazol-5- yl}propan-2-ol::US10308645, Example 39 Orexin receptor type 2 Homo sapiens 53.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395700&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314580 405265779 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790953 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1OC(F)(F)F)c1nsc(n1)C(C)(C)O InChI=1S/C19H22F3N3O3S/c1-11-8-9-12(15-23-17(29-24-15)18(2,3)27)10-25(11)16(26)13-6-4-5-7-14(13)28-19(20,21)22/h4-7,11-12,27H,8-10H2,1-3H3/t11-,12-/m1/s1 MBIBUCDOLLSHMQ-VXGBXAGGSA-N 395700 2-{3-[(3R,6R)-6-methyl-1-{[2- (trifluoromethoxy)phenyl]carbonyl} piperidin-3-yl]-1,2,4-thiadiazol-5- yl}propan-2-ol::US10308645, Example 39 Orexin/Hypocretin receptor type 1 Homo sapiens 6385 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395700&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314580 405265779 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790954 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)c1nsc(n1)C(C)(C)O InChI=1S/C20H23N5O2S2/c1-12-5-6-13(16-23-19(29-24-16)20(2,3)27)11-25(12)18(26)14-7-10-28-15(14)17-21-8-4-9-22-17/h4,7-10,12-13,27H,5-6,11H2,1-3H3/t12-,13-/m1/s1 YVUHVBMFXPIZRD-CHWSQXEVSA-N 395701 2-(3-{(3R,6R)-6-Methyl-1-[(2-pyrimidin-2-ylthiophen-3-yl)carbonyl]piperidin-3-yl}-1,2,4-thiadiazol-5-yl)propan-2-ol::US10308645, Example 40 Orexin receptor type 2 Homo sapiens 50.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395701&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305963 405265780 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790955 C[C@@H]1CC[C@H](CN1C(=O)c1ccsc1-c1ncccn1)c1nsc(n1)C(C)(C)O InChI=1S/C20H23N5O2S2/c1-12-5-6-13(16-23-19(29-24-16)20(2,3)27)11-25(12)18(26)14-7-10-28-15(14)17-21-8-4-9-22-17/h4,7-10,12-13,27H,5-6,11H2,1-3H3/t12-,13-/m1/s1 YVUHVBMFXPIZRD-CHWSQXEVSA-N 395701 2-(3-{(3R,6R)-6-Methyl-1-[(2-pyrimidin-2-ylthiophen-3-yl)carbonyl]piperidin-3-yl}-1,2,4-thiadiazol-5-yl)propan-2-ol::US10308645, Example 40 Orexin/Hypocretin receptor type 1 Homo sapiens 9991 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395701&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305963 405265780 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790956 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1nsc(n1)C(C)(C)O InChI=1S/C22H25N5O2S/c1-14-9-10-15(18-25-21(30-26-18)22(2,3)29)13-27(14)20(28)17-8-5-4-7-16(17)19-23-11-6-12-24-19/h4-8,11-12,14-15,29H,9-10,13H2,1-3H3/t14-,15-/m1/s1 SAEQFAPSCBVFPC-HUUCEWRRSA-N 395702 2-(3-{(3R,6R)-6-Methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl}-1,2,4-thiadiazol-5-yl)propan-2-ol::US10308645, Example 41 Orexin receptor type 2 Homo sapiens 48.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395702&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305962 405265781 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790957 C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-c1ncccn1)c1nsc(n1)C(C)(C)O InChI=1S/C22H25N5O2S/c1-14-9-10-15(18-25-21(30-26-18)22(2,3)29)13-27(14)20(28)17-8-5-4-7-16(17)19-23-11-6-12-24-19/h4-8,11-12,14-15,29H,9-10,13H2,1-3H3/t14-,15-/m1/s1 SAEQFAPSCBVFPC-HUUCEWRRSA-N 395702 2-(3-{(3R,6R)-6-Methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl}-1,2,4-thiadiazol-5-yl)propan-2-ol::US10308645, Example 41 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395702&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305962 405265781 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790958 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-c1ncccn1)c1nsc(n1)C(C)(C)O InChI=1S/C20H23N5O2S2/c1-12-5-6-13(16-23-19(29-24-16)20(2,3)27)9-25(12)18(26)15-11-28-10-14(15)17-21-7-4-8-22-17/h4,7-8,10-13,27H,5-6,9H2,1-3H3/t12-,13-/m1/s1 WMFHXBOWFZCBEQ-CHWSQXEVSA-N 395703 2-(3-{(3R,6R)-6-methyl-1-[(4-pyrimidin- 2-ylthiophen-3-yl)carbonyl]piperidin-3- yl}-1,2,4-thiadiazol-5-yl)propan-2-ol::US10308645, Example 42 Orexin receptor type 2 Homo sapiens 83.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395703&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121314529 405265782 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790959 C[C@@H]1CC[C@H](CN1C(=O)c1cscc1-c1ncccn1)c1nsc(n1)C(C)(C)O InChI=1S/C20H23N5O2S2/c1-12-5-6-13(16-23-19(29-24-16)20(2,3)27)9-25(12)18(26)15-11-28-10-14(15)17-21-7-4-8-22-17/h4,7-8,10-13,27H,5-6,9H2,1-3H3/t12-,13-/m1/s1 WMFHXBOWFZCBEQ-CHWSQXEVSA-N 395703 2-(3-{(3R,6R)-6-methyl-1-[(4-pyrimidin- 2-ylthiophen-3-yl)carbonyl]piperidin-3- yl}-1,2,4-thiadiazol-5-yl)propan-2-ol::US10308645, Example 42 Orexin/Hypocretin receptor type 1 Homo sapiens 10000 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395703&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121314529 405265782 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 790960 COC(C)(C)c1nc(ns1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H26N6O2S/c1-14-9-10-15(18-24-20(30-25-18)21(2,3)29-4)13-26(14)19(28)16-7-5-6-8-17(16)27-22-11-12-23-27/h5-8,11-12,14-15H,9-10,13H2,1-4H3/t14-,15-/m1/s1 LFQUOFULHDQDHO-HUUCEWRRSA-N 395704 (2R,5R)-5-[5-(1-methoxy-1-methylethyl)-1,2,4-thiadiazol-3-yl]-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine::US10308645, Example 43 Orexin receptor type 2 Homo sapiens 39.0 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395704&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 121305976 405265783 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 790961 COC(C)(C)c1nc(ns1)[C@@H]1CC[C@@H](C)N(C1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H26N6O2S/c1-14-9-10-15(18-24-20(30-25-18)21(2,3)29-4)13-26(14)19(28)16-7-5-6-8-17(16)27-22-11-12-23-27/h5-8,11-12,14-15H,9-10,13H2,1-4H3/t14-,15-/m1/s1 LFQUOFULHDQDHO-HUUCEWRRSA-N 395704 (2R,5R)-5-[5-(1-methoxy-1-methylethyl)-1,2,4-thiadiazol-3-yl]-2-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidine::US10308645, Example 43 Orexin/Hypocretin receptor type 1 Homo sapiens 1411 US Patent 10.7270/Q2WH2SBM aid1799058 US10308645 Liverton, N; Kuduk, SD; Luo, Y; Meng, N; Yu, T 6/4/2019 4/15/2020 Merck Sharp & Dohme Corp http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=395704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=395704&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 121305976 405265783 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6